Recent events in south Asia have led to an unexpected reversal in the narrative of microfinance, long presented as a development success. Despite charges of poor treatment of clients, exaggeration of the impact on the poorest as well as the risks of credit bubbles, the sector can play a non-negligible role in reaching financial services to low-income households. In regulating the sector, there is need for caution in setting interest...

Assam tea has failed to capture the market in the very country whose planters made it a marketable commodity in the state 150 years ago. The situation, however, can be turned around with a better marketing strategy, Mark Kibblewhite, an eminent tea scientist and a professor at Cranfield University in the UK, told The Telegraph on the sidelines of World Tea Science Congress which began at Tocklai Experimental Station at Cinnamara,...

Two months ago, Cabinet approved a draft law that seeks to create a better legislative environment to attract investments in mining and ease land acquisition through higher compensation to people displaced by projects. This show of goodwill could help the government win some hearts in troubled landscapes of Orissa and Karnataka.  But mining companies are not entirely convinced as they have to pay higher royalties and want changes to be made...

Indian suppliers must be units with investment up to Rs 1.25 cr, says draft before cabinet. Multinational retailers such as Walmart, Tesco and Carrefour looking to open stores in the country may have to source almost a third of their merchandise from small Indian manufacturers as the government tries to make the opening of multi-brand retail to foreign players more politically palatable. The draft cabinet note for permitting 51 per cent foreign...

New drug pricing policy proposes bringing all essential medicines under price control, but makes them expensive After years of dilly-dallying and several Supreme Court reminders, the Centre has proposed to bring all essential drugs under price control. But the policy is nothing but hogwash. Its pricing mechanism would make essential medicines out of reach for most people. Public health experts have termed the draft National Pharmaceutical Pricing Policy of 2011 a...